FDA Roundup: July 2, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-2-2024

FDA Roundup: June 28, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-28-2024

FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
http://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-point-care-hepatitis-c-rna-test

FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies
http://www.fda.gov/news-events/press-announcements/fda-guidance-provides-new-details-diversity-action-plans-required-certain-clinical-studies

FDA Roundup: June 25, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-25-2024

FDA Roundup: June 21, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-21-2024

FDA Authorizes Marketing of Four Menthol-Flavored E-Cigarette Products After Extensive Scientific Review
http://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-four-menthol-flavored-e-cigarette-products-after-extensive-scientific

FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy
http://www.fda.gov/news-events/press-announcements/fda-expands-approval-gene-therapy-patients-duchenne-muscular-dystrophy

http://www.fda.gov/medical-devices/safety-communications/update-evaluating-plastic-syringes-made-china-potential-device-failures-fda-safety-communication

FDA Roundup: June 18, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-18-2024